Genomics Market By Product (Consumables and Reagent, Services, Instruments, Systems and Software) , By Technology (Sequencing, PCR, Flow Cytometry, Microarray, Others) By Application (Functional Genomics, Epigenomics, Pathway Analysis, Biomarker Discovery, Others) By End User (Clinical Research, Academic and Government Institutions, Hospitals and Clinics, Pharmaceutical and Biotechnology Companies, Others) : Global Opportunity Analysis and Industry Forecast, 2024-2033
Genomics Market
The genomics market was valued at $33.2 billion in 2023 and is projected to reach $97.1 billion by 2033, growing at a CAGR of 11.5% from 2024 to 2033.
Genomics is the branch of molecular biology that involves the study of structure, function, mapping, evolution, and editing of the genome of living organisms. A genome is defined as the entire set of an individual’s deoxyribonucleic acid (DNA). DNA is an essential chemical compound present inside a living body that contains the critical information for the development and functioning of the body. The major role of genomics is to determine the sequence of molecules which form the DNA content of organisms.
Increase in the integration of genomics into healthcare through personalized treatment plans, diagnosis of diseases, and genetic testing is driving the development of the market. In addition, constant efforts toward new drug development are boosting the demand for innovative genomics technology. In recent times, 3D and spatial genomics is a flourishing trend that involves studying the spatial positioning of chromatin inside the nucleus. This technology is predicted to revolutionize the field of human health and medicine owing to the novel insights it provides into the genetic makeup of individuals.
However, the high expense of establishing genomics laboratories and infrastructure acts as a key restraint for the growth of the market. In addition, the high risk associated with the misuse of genetic data limits market development. According to an article by the National Center for Biotechnology Information, every year millions of individuals dynamically provide unlimited access of their health information to different institutions for multiple uses, including insurance and commercial transactions. The sharing of data is highly extensive such that the information becomes available to institutions not covered under Health Insurance Portability and Accountability Act (HIPPA), thereby losing the security offered by the HIPAA Privacy Rule.
Segment Review
The genomics market is segmented into product, technology, application, end user, and region. On the basis of product, the market is divided into consumables & reagent, services, instruments, systems and software. By technology, it is classified into sequencing, PCR, flow cytometry, microarray, and others. As per application, it is categorized into functional genomics, epigenomics, pathway analysis, biomarker discovery, and others. Depending on end user, it is segmented into clinical research, academic & government institutions, hospitals & clinics, pharmaceutical & biotechnology companies, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Findings
On the basis of product, the consumables & reagent segment dominated the market in 2023.
By technology, the sequencing segment held the highest market share in 2023.
As per application, the functional genomics segment acquired a high stake in the market in 2023.
Depending on end user, the pharmaceutical & biotechnology companies segment was the highest shareholder in 2023.
Region wise, North America was the highest revenue generator in 2023.
Competition Analysis
The leading players operating in the global genomics market include Color Genomics, Inc., BGI Genomics, Agilent Technologies, Danaher Corporation, Eppendorf AG, Eurofins Scientific SE, F. Hoffmann-La Roche Ltd., GE Healthcare, Illumina, Inc., and Bio-Rad Laboratories, Inc. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships, to strengthen their foothold in the competitive market.
Key Market Segments
By Product
Consumables and Reagent
Services
Instruments, Systems and Software
By Technology
Sequencing
PCR
Flow Cytometry
Microarray
Others
By Application
Functional Genomics
Epigenomics
Pathway Analysis
Biomarker Discovery
Others
By End User
Clinical Research
Academic and Government Institutions
Hospitals and Clinics
Pharmaceutical and Biotechnology Companies
Others
By Region
North America
U.S.
Canada
Mexico
Europe
France
Germany
Italy
Spain
UK
Rest of Europe
Asia-Pacific
China
Japan
India
South Korea
Australia
Rest of Asia-Pacific
LAMEA
Brazil
South Africa
Saudi Arabia
UAE
Rest of LAMEA
Key Market Players
Color Genomics, Inc.
BGI Genomics
Agilent Technologies
Danaher Corporation
Eppendorf AG
Eurofins Scientific SE
F. Hoffmann-La Roche Ltd.
GE Healthcare
Illumina, Inc.
Bio-Rad Laboratories, Inc.
- CHAPTER 1: INTRODUCTION
- 1.1. Report Description
- 1.2. Key Market Segments
- 1.3. Key Benefits
- 1.4. Research Methodology
- 1.4.1. Primary Research
- 1.4.2. Secondary Research
- 1.4.3. Analyst Tools and Models
- CHAPTER 2: EXECUTIVE SUMMARY
- 2.1. CXO Perspective
- CHAPTER 3: MARKET LANDSCAPE
- 3.1. Market Definition and Scope
- 3.2. Key Findings
- 3.2.1. Top Investment Pockets
- 3.2.2. Top Winning Strategies
- 3.3. Porter's Five Forces Analysis
- 3.3.1. Bargaining Power of Suppliers
- 3.3.2. Threat of New Entrants
- 3.3.3. Threat of Substitutes
- 3.3.4. Competitive Rivalry
- 3.3.5. Bargaining Power among Buyers
- 3.4. Market Dynamics
- 3.4.1. Drivers
- 3.4.2. Restraints
- 3.4.3. Opportunities
- CHAPTER 4: GENOMICS MARKET, BY PRODUCT
- 4.1. Market Overview
- 4.1.1 Market Size and Forecast, By Product
- 4.2. Consumables And Reagent
- 4.2.1. Key Market Trends, Growth Factors and Opportunities
- 4.2.2. Market Size and Forecast, By Region
- 4.2.3. Market Share Analysis, By Country
- 4.3. Services
- 4.3.1. Key Market Trends, Growth Factors and Opportunities
- 4.3.2. Market Size and Forecast, By Region
- 4.3.3. Market Share Analysis, By Country
- 4.4. Instruments, Systems And Software
- 4.4.1. Key Market Trends, Growth Factors and Opportunities
- 4.4.2. Market Size and Forecast, By Region
- 4.4.3. Market Share Analysis, By Country
- CHAPTER 5: GENOMICS MARKET, BY TECHNOLOGY
- 5.1. Market Overview
- 5.1.1 Market Size and Forecast, By Technology
- 5.2. Sequencing
- 5.2.1. Key Market Trends, Growth Factors and Opportunities
- 5.2.2. Market Size and Forecast, By Region
- 5.2.3. Market Share Analysis, By Country
- 5.3. PCR
- 5.3.1. Key Market Trends, Growth Factors and Opportunities
- 5.3.2. Market Size and Forecast, By Region
- 5.3.3. Market Share Analysis, By Country
- 5.4. Flow Cytometry
- 5.4.1. Key Market Trends, Growth Factors and Opportunities
- 5.4.2. Market Size and Forecast, By Region
- 5.4.3. Market Share Analysis, By Country
- 5.5. Microarray
- 5.5.1. Key Market Trends, Growth Factors and Opportunities
- 5.5.2. Market Size and Forecast, By Region
- 5.5.3. Market Share Analysis, By Country
- 5.6. Others
- 5.6.1. Key Market Trends, Growth Factors and Opportunities
- 5.6.2. Market Size and Forecast, By Region
- 5.6.3. Market Share Analysis, By Country
- CHAPTER 6: GENOMICS MARKET, BY APPLICATION
- 6.1. Market Overview
- 6.1.1 Market Size and Forecast, By Application
- 6.2. Functional Genomics
- 6.2.1. Key Market Trends, Growth Factors and Opportunities
- 6.2.2. Market Size and Forecast, By Region
- 6.2.3. Market Share Analysis, By Country
- 6.3. Epigenomics
- 6.3.1. Key Market Trends, Growth Factors and Opportunities
- 6.3.2. Market Size and Forecast, By Region
- 6.3.3. Market Share Analysis, By Country
- 6.4. Pathway Analysis
- 6.4.1. Key Market Trends, Growth Factors and Opportunities
- 6.4.2. Market Size and Forecast, By Region
- 6.4.3. Market Share Analysis, By Country
- 6.5. Biomarker Discovery
- 6.5.1. Key Market Trends, Growth Factors and Opportunities
- 6.5.2. Market Size and Forecast, By Region
- 6.5.3. Market Share Analysis, By Country
- 6.6. Others
- 6.6.1. Key Market Trends, Growth Factors and Opportunities
- 6.6.2. Market Size and Forecast, By Region
- 6.6.3. Market Share Analysis, By Country
- CHAPTER 7: GENOMICS MARKET, BY END USER
- 7.1. Market Overview
- 7.1.1 Market Size and Forecast, By End User
- 7.2. Clinical Research
- 7.2.1. Key Market Trends, Growth Factors and Opportunities
- 7.2.2. Market Size and Forecast, By Region
- 7.2.3. Market Share Analysis, By Country
- 7.3. Academic And Government Institutions
- 7.3.1. Key Market Trends, Growth Factors and Opportunities
- 7.3.2. Market Size and Forecast, By Region
- 7.3.3. Market Share Analysis, By Country
- 7.4. Hospitals And Clinics
- 7.4.1. Key Market Trends, Growth Factors and Opportunities
- 7.4.2. Market Size and Forecast, By Region
- 7.4.3. Market Share Analysis, By Country
- 7.5. Pharmaceutical And Biotechnology Companies
- 7.5.1. Key Market Trends, Growth Factors and Opportunities
- 7.5.2. Market Size and Forecast, By Region
- 7.5.3. Market Share Analysis, By Country
- 7.6. Others
- 7.6.1. Key Market Trends, Growth Factors and Opportunities
- 7.6.2. Market Size and Forecast, By Region
- 7.6.3. Market Share Analysis, By Country
- CHAPTER 8: GENOMICS MARKET, BY REGION
- 8.1. Market Overview
- 8.1.1 Market Size and Forecast, By Region
- 8.2. North America
- 8.2.1. Key Market Trends and Opportunities
- 8.2.2. Market Size and Forecast, By Product
- 8.2.3. Market Size and Forecast, By Technology
- 8.2.4. Market Size and Forecast, By Application
- 8.2.5. Market Size and Forecast, By End User
- 8.2.6. Market Size and Forecast, By Country
- 8.2.7. U.S. Genomics Market
- 8.2.7.1. Market Size and Forecast, By Product
- 8.2.7.2. Market Size and Forecast, By Technology
- 8.2.7.3. Market Size and Forecast, By Application
- 8.2.7.4. Market Size and Forecast, By End User
- 8.2.8. Canada Genomics Market
- 8.2.8.1. Market Size and Forecast, By Product
- 8.2.8.2. Market Size and Forecast, By Technology
- 8.2.8.3. Market Size and Forecast, By Application
- 8.2.8.4. Market Size and Forecast, By End User
- 8.2.9. Mexico Genomics Market
- 8.2.9.1. Market Size and Forecast, By Product
- 8.2.9.2. Market Size and Forecast, By Technology
- 8.2.9.3. Market Size and Forecast, By Application
- 8.2.9.4. Market Size and Forecast, By End User
- 8.3. Europe
- 8.3.1. Key Market Trends and Opportunities
- 8.3.2. Market Size and Forecast, By Product
- 8.3.3. Market Size and Forecast, By Technology
- 8.3.4. Market Size and Forecast, By Application
- 8.3.5. Market Size and Forecast, By End User
- 8.3.6. Market Size and Forecast, By Country
- 8.3.7. France Genomics Market
- 8.3.7.1. Market Size and Forecast, By Product
- 8.3.7.2. Market Size and Forecast, By Technology
- 8.3.7.3. Market Size and Forecast, By Application
- 8.3.7.4. Market Size and Forecast, By End User
- 8.3.8. Germany Genomics Market
- 8.3.8.1. Market Size and Forecast, By Product
- 8.3.8.2. Market Size and Forecast, By Technology
- 8.3.8.3. Market Size and Forecast, By Application
- 8.3.8.4. Market Size and Forecast, By End User
- 8.3.9. Italy Genomics Market
- 8.3.9.1. Market Size and Forecast, By Product
- 8.3.9.2. Market Size and Forecast, By Technology
- 8.3.9.3. Market Size and Forecast, By Application
- 8.3.9.4. Market Size and Forecast, By End User
- 8.3.10. Spain Genomics Market
- 8.3.10.1. Market Size and Forecast, By Product
- 8.3.10.2. Market Size and Forecast, By Technology
- 8.3.10.3. Market Size and Forecast, By Application
- 8.3.10.4. Market Size and Forecast, By End User
- 8.3.11. UK Genomics Market
- 8.3.11.1. Market Size and Forecast, By Product
- 8.3.11.2. Market Size and Forecast, By Technology
- 8.3.11.3. Market Size and Forecast, By Application
- 8.3.11.4. Market Size and Forecast, By End User
- 8.3.12. Rest Of Europe Genomics Market
- 8.3.12.1. Market Size and Forecast, By Product
- 8.3.12.2. Market Size and Forecast, By Technology
- 8.3.12.3. Market Size and Forecast, By Application
- 8.3.12.4. Market Size and Forecast, By End User
- 8.4. Asia-Pacific
- 8.4.1. Key Market Trends and Opportunities
- 8.4.2. Market Size and Forecast, By Product
- 8.4.3. Market Size and Forecast, By Technology
- 8.4.4. Market Size and Forecast, By Application
- 8.4.5. Market Size and Forecast, By End User
- 8.4.6. Market Size and Forecast, By Country
- 8.4.7. China Genomics Market
- 8.4.7.1. Market Size and Forecast, By Product
- 8.4.7.2. Market Size and Forecast, By Technology
- 8.4.7.3. Market Size and Forecast, By Application
- 8.4.7.4. Market Size and Forecast, By End User
- 8.4.8. Japan Genomics Market
- 8.4.8.1. Market Size and Forecast, By Product
- 8.4.8.2. Market Size and Forecast, By Technology
- 8.4.8.3. Market Size and Forecast, By Application
- 8.4.8.4. Market Size and Forecast, By End User
- 8.4.9. India Genomics Market
- 8.4.9.1. Market Size and Forecast, By Product
- 8.4.9.2. Market Size and Forecast, By Technology
- 8.4.9.3. Market Size and Forecast, By Application
- 8.4.9.4. Market Size and Forecast, By End User
- 8.4.10. South Korea Genomics Market
- 8.4.10.1. Market Size and Forecast, By Product
- 8.4.10.2. Market Size and Forecast, By Technology
- 8.4.10.3. Market Size and Forecast, By Application
- 8.4.10.4. Market Size and Forecast, By End User
- 8.4.11. Australia Genomics Market
- 8.4.11.1. Market Size and Forecast, By Product
- 8.4.11.2. Market Size and Forecast, By Technology
- 8.4.11.3. Market Size and Forecast, By Application
- 8.4.11.4. Market Size and Forecast, By End User
- 8.4.12. Rest of Asia-Pacific Genomics Market
- 8.4.12.1. Market Size and Forecast, By Product
- 8.4.12.2. Market Size and Forecast, By Technology
- 8.4.12.3. Market Size and Forecast, By Application
- 8.4.12.4. Market Size and Forecast, By End User
- 8.5. LAMEA
- 8.5.1. Key Market Trends and Opportunities
- 8.5.2. Market Size and Forecast, By Product
- 8.5.3. Market Size and Forecast, By Technology
- 8.5.4. Market Size and Forecast, By Application
- 8.5.5. Market Size and Forecast, By End User
- 8.5.6. Market Size and Forecast, By Country
- 8.5.7. Brazil Genomics Market
- 8.5.7.1. Market Size and Forecast, By Product
- 8.5.7.2. Market Size and Forecast, By Technology
- 8.5.7.3. Market Size and Forecast, By Application
- 8.5.7.4. Market Size and Forecast, By End User
- 8.5.8. South Africa Genomics Market
- 8.5.8.1. Market Size and Forecast, By Product
- 8.5.8.2. Market Size and Forecast, By Technology
- 8.5.8.3. Market Size and Forecast, By Application
- 8.5.8.4. Market Size and Forecast, By End User
- 8.5.9. Saudi Arabia Genomics Market
- 8.5.9.1. Market Size and Forecast, By Product
- 8.5.9.2. Market Size and Forecast, By Technology
- 8.5.9.3. Market Size and Forecast, By Application
- 8.5.9.4. Market Size and Forecast, By End User
- 8.5.10. UAE Genomics Market
- 8.5.10.1. Market Size and Forecast, By Product
- 8.5.10.2. Market Size and Forecast, By Technology
- 8.5.10.3. Market Size and Forecast, By Application
- 8.5.10.4. Market Size and Forecast, By End User
- 8.5.11. Rest of LAMEA Genomics Market
- 8.5.11.1. Market Size and Forecast, By Product
- 8.5.11.2. Market Size and Forecast, By Technology
- 8.5.11.3. Market Size and Forecast, By Application
- 8.5.11.4. Market Size and Forecast, By End User
- CHAPTER 9: COMPETITIVE LANDSCAPE
- 9.1. Introduction
- 9.2. Top Winning Strategies
- 9.3. Product Mapping Of Top 10 Player
- 9.4. Competitive Dashboard
- 9.5. Competitive Heatmap
- 9.6. Top Player Positioning, 2023
- CHAPTER 10: COMPANY PROFILES
- 10.1. Color Genomics, Inc.
- 10.1.1. Company Overview
- 10.1.2. Key Executives
- 10.1.3. Company Snapshot
- 10.1.4. Operating Business Segments
- 10.1.5. Product Portfolio
- 10.1.6. Business Performance
- 10.1.7. Key Strategic Moves and Developments
- 10.2. BGI Genomics
- 10.2.1. Company Overview
- 10.2.2. Key Executives
- 10.2.3. Company Snapshot
- 10.2.4. Operating Business Segments
- 10.2.5. Product Portfolio
- 10.2.6. Business Performance
- 10.2.7. Key Strategic Moves and Developments
- 10.3. Agilent Technologies
- 10.3.1. Company Overview
- 10.3.2. Key Executives
- 10.3.3. Company Snapshot
- 10.3.4. Operating Business Segments
- 10.3.5. Product Portfolio
- 10.3.6. Business Performance
- 10.3.7. Key Strategic Moves and Developments
- 10.4. Danaher Corporation
- 10.4.1. Company Overview
- 10.4.2. Key Executives
- 10.4.3. Company Snapshot
- 10.4.4. Operating Business Segments
- 10.4.5. Product Portfolio
- 10.4.6. Business Performance
- 10.4.7. Key Strategic Moves and Developments
- 10.5. Eppendorf AG
- 10.5.1. Company Overview
- 10.5.2. Key Executives
- 10.5.3. Company Snapshot
- 10.5.4. Operating Business Segments
- 10.5.5. Product Portfolio
- 10.5.6. Business Performance
- 10.5.7. Key Strategic Moves and Developments
- 10.6. Eurofins Scientific SE
- 10.6.1. Company Overview
- 10.6.2. Key Executives
- 10.6.3. Company Snapshot
- 10.6.4. Operating Business Segments
- 10.6.5. Product Portfolio
- 10.6.6. Business Performance
- 10.6.7. Key Strategic Moves and Developments
- 10.7. F. Hoffmann-La Roche Ltd.
- 10.7.1. Company Overview
- 10.7.2. Key Executives
- 10.7.3. Company Snapshot
- 10.7.4. Operating Business Segments
- 10.7.5. Product Portfolio
- 10.7.6. Business Performance
- 10.7.7. Key Strategic Moves and Developments
- 10.8. GE Healthcare
- 10.8.1. Company Overview
- 10.8.2. Key Executives
- 10.8.3. Company Snapshot
- 10.8.4. Operating Business Segments
- 10.8.5. Product Portfolio
- 10.8.6. Business Performance
- 10.8.7. Key Strategic Moves and Developments
- 10.9. Illumina, Inc.
- 10.9.1. Company Overview
- 10.9.2. Key Executives
- 10.9.3. Company Snapshot
- 10.9.4. Operating Business Segments
- 10.9.5. Product Portfolio
- 10.9.6. Business Performance
- 10.9.7. Key Strategic Moves and Developments
- 10.10. Bio-Rad Laboratories, Inc.
- 10.10.1. Company Overview
- 10.10.2. Key Executives
- 10.10.3. Company Snapshot
- 10.10.4. Operating Business Segments
- 10.10.5. Product Portfolio
- 10.10.6. Business Performance
- 10.10.7. Key Strategic Moves and Developments
- TABLE 1. GLOBAL GENOMICS MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 2. GENOMICS MARKET FOR CONSUMABLES AND REAGENT, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 3. GENOMICS MARKET FOR SERVICES, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 4. GENOMICS MARKET FOR INSTRUMENTS, SYSTEMS AND SOFTWARE, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 5. GLOBAL GENOMICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
- TABLE 6. GENOMICS MARKET FOR SEQUENCING, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 7. GENOMICS MARKET FOR PCR, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 8. GENOMICS MARKET FOR FLOW CYTOMETRY, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 9. GENOMICS MARKET FOR MICROARRAY, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 10. GENOMICS MARKET FOR OTHERS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 11. GLOBAL GENOMICS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 12. GENOMICS MARKET FOR FUNCTIONAL GENOMICS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 13. GENOMICS MARKET FOR EPIGENOMICS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 14. GENOMICS MARKET FOR PATHWAY ANALYSIS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 15. GENOMICS MARKET FOR BIOMARKER DISCOVERY, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 16. GENOMICS MARKET FOR OTHERS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 17. GLOBAL GENOMICS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 18. GENOMICS MARKET FOR CLINICAL RESEARCH, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 19. GENOMICS MARKET FOR ACADEMIC AND GOVERNMENT INSTITUTIONS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 20. GENOMICS MARKET FOR HOSPITALS AND CLINICS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 21. GENOMICS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 22. GENOMICS MARKET FOR OTHERS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 23. GENOMICS MARKET, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 24. NORTH AMERICA GENOMICS MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 25. NORTH AMERICA GENOMICS MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 26. NORTH AMERICA GENOMICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
- TABLE 27. NORTH AMERICA GENOMICS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 28. NORTH AMERICA GENOMICS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 29. U.S. GENOMICS MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 30. U.S. GENOMICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
- TABLE 31. U.S. GENOMICS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 32. U.S. GENOMICS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 33. CANADA GENOMICS MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 34. CANADA GENOMICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
- TABLE 35. CANADA GENOMICS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 36. CANADA GENOMICS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 37. MEXICO GENOMICS MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 38. MEXICO GENOMICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
- TABLE 39. MEXICO GENOMICS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 40. MEXICO GENOMICS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 41. EUROPE GENOMICS MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 42. EUROPE GENOMICS MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 43. EUROPE GENOMICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
- TABLE 44. EUROPE GENOMICS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 45. EUROPE GENOMICS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 46. FRANCE GENOMICS MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 47. FRANCE GENOMICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
- TABLE 48. FRANCE GENOMICS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 49. FRANCE GENOMICS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 50. GERMANY GENOMICS MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 51. GERMANY GENOMICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
- TABLE 52. GERMANY GENOMICS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 53. GERMANY GENOMICS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 54. ITALY GENOMICS MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 55. ITALY GENOMICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
- TABLE 56. ITALY GENOMICS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 57. ITALY GENOMICS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 58. SPAIN GENOMICS MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 59. SPAIN GENOMICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
- TABLE 60. SPAIN GENOMICS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 61. SPAIN GENOMICS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 62. UK GENOMICS MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 63. UK GENOMICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
- TABLE 64. UK GENOMICS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 65. UK GENOMICS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 66. REST OF EUROPE GENOMICS MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 67. REST OF EUROPE GENOMICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
- TABLE 68. REST OF EUROPE GENOMICS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 69. REST OF EUROPE GENOMICS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 70. ASIA-PACIFIC GENOMICS MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 71. ASIA-PACIFIC GENOMICS MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 72. ASIA-PACIFIC GENOMICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
- TABLE 73. ASIA-PACIFIC GENOMICS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 74. ASIA-PACIFIC GENOMICS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 75. CHINA GENOMICS MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 76. CHINA GENOMICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
- TABLE 77. CHINA GENOMICS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 78. CHINA GENOMICS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 79. JAPAN GENOMICS MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 80. JAPAN GENOMICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
- TABLE 81. JAPAN GENOMICS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 82. JAPAN GENOMICS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 83. INDIA GENOMICS MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 84. INDIA GENOMICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
- TABLE 85. INDIA GENOMICS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 86. INDIA GENOMICS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 87. SOUTH KOREA GENOMICS MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 88. SOUTH KOREA GENOMICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
- TABLE 89. SOUTH KOREA GENOMICS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 90. SOUTH KOREA GENOMICS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 91. AUSTRALIA GENOMICS MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 92. AUSTRALIA GENOMICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
- TABLE 93. AUSTRALIA GENOMICS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 94. AUSTRALIA GENOMICS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 95. REST OF ASIA-PACIFIC GENOMICS MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 96. REST OF ASIA-PACIFIC GENOMICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
- TABLE 97. REST OF ASIA-PACIFIC GENOMICS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 98. REST OF ASIA-PACIFIC GENOMICS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 99. LAMEA GENOMICS MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 100. LAMEA GENOMICS MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 101. LAMEA GENOMICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
- TABLE 102. LAMEA GENOMICS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 103. LAMEA GENOMICS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 104. BRAZIL GENOMICS MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 105. BRAZIL GENOMICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
- TABLE 106. BRAZIL GENOMICS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 107. BRAZIL GENOMICS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 108. SOUTH AFRICA GENOMICS MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 109. SOUTH AFRICA GENOMICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
- TABLE 110. SOUTH AFRICA GENOMICS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 111. SOUTH AFRICA GENOMICS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 112. SAUDI ARABIA GENOMICS MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 113. SAUDI ARABIA GENOMICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
- TABLE 114. SAUDI ARABIA GENOMICS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 115. SAUDI ARABIA GENOMICS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 116. UAE GENOMICS MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 117. UAE GENOMICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
- TABLE 118. UAE GENOMICS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 119. UAE GENOMICS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 120. REST OF LAMEA GENOMICS MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 121. REST OF LAMEA GENOMICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
- TABLE 122. REST OF LAMEA GENOMICS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 123. REST OF LAMEA GENOMICS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 124. COLOR GENOMICS, INC.: KEY EXECUTIVES
- TABLE 125. COLOR GENOMICS, INC.: COMPANY SNAPSHOT
- TABLE 126. COLOR GENOMICS, INC.: OPERATING SEGMENTS
- TABLE 127. COLOR GENOMICS, INC.: PRODUCT PORTFOLIO
- TABLE 128. COLOR GENOMICS, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 129. BGI GENOMICS: KEY EXECUTIVES
- TABLE 130. BGI GENOMICS: COMPANY SNAPSHOT
- TABLE 131. BGI GENOMICS: OPERATING SEGMENTS
- TABLE 132. BGI GENOMICS: PRODUCT PORTFOLIO
- TABLE 133. BGI GENOMICS: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 134. AGILENT TECHNOLOGIES: KEY EXECUTIVES
- TABLE 135. AGILENT TECHNOLOGIES: COMPANY SNAPSHOT
- TABLE 136. AGILENT TECHNOLOGIES: OPERATING SEGMENTS
- TABLE 137. AGILENT TECHNOLOGIES: PRODUCT PORTFOLIO
- TABLE 138. AGILENT TECHNOLOGIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 139. DANAHER CORPORATION: KEY EXECUTIVES
- TABLE 140. DANAHER CORPORATION: COMPANY SNAPSHOT
- TABLE 141. DANAHER CORPORATION: OPERATING SEGMENTS
- TABLE 142. DANAHER CORPORATION: PRODUCT PORTFOLIO
- TABLE 143. DANAHER CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 144. EPPENDORF AG: KEY EXECUTIVES
- TABLE 145. EPPENDORF AG: COMPANY SNAPSHOT
- TABLE 146. EPPENDORF AG: OPERATING SEGMENTS
- TABLE 147. EPPENDORF AG: PRODUCT PORTFOLIO
- TABLE 148. EPPENDORF AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 149. EUROFINS SCIENTIFIC SE: KEY EXECUTIVES
- TABLE 150. EUROFINS SCIENTIFIC SE: COMPANY SNAPSHOT
- TABLE 151. EUROFINS SCIENTIFIC SE: OPERATING SEGMENTS
- TABLE 152. EUROFINS SCIENTIFIC SE: PRODUCT PORTFOLIO
- TABLE 153. EUROFINS SCIENTIFIC SE: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 154. F. HOFFMANN-LA ROCHE LTD.: KEY EXECUTIVES
- TABLE 155. F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT
- TABLE 156. F. HOFFMANN-LA ROCHE LTD.: OPERATING SEGMENTS
- TABLE 157. F. HOFFMANN-LA ROCHE LTD.: PRODUCT PORTFOLIO
- TABLE 158. F. HOFFMANN-LA ROCHE LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 159. GE HEALTHCARE: KEY EXECUTIVES
- TABLE 160. GE HEALTHCARE: COMPANY SNAPSHOT
- TABLE 161. GE HEALTHCARE: OPERATING SEGMENTS
- TABLE 162. GE HEALTHCARE: PRODUCT PORTFOLIO
- TABLE 163. GE HEALTHCARE: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 164. ILLUMINA, INC.: KEY EXECUTIVES
- TABLE 165. ILLUMINA, INC.: COMPANY SNAPSHOT
- TABLE 166. ILLUMINA, INC.: OPERATING SEGMENTS
- TABLE 167. ILLUMINA, INC.: PRODUCT PORTFOLIO
- TABLE 168. ILLUMINA, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 169. BIO-RAD LABORATORIES, INC. : KEY EXECUTIVES
- TABLE 170. BIO-RAD LABORATORIES, INC. : COMPANY SNAPSHOT
- TABLE 171. BIO-RAD LABORATORIES, INC. : OPERATING SEGMENTS
- TABLE 172. BIO-RAD LABORATORIES, INC. : PRODUCT PORTFOLIO
- TABLE 173. BIO-RAD LABORATORIES, INC. : KEY STRATEGIC MOVES AND DEVELOPMENTS
- FIGURE 1. GLOBAL GENOMICS MARKET, 2024 - 2033
- FIGURE 2. SEGMENTATION OF GENOMICS MARKET, 2024 - 2033
- FIGURE 3. TOP INVESTMENT POCKET IN GENOMICS MARKET
- FIGURE 4. MODERATE BARGAINING POWER OF BUYERS
- FIGURE 5. MODERATE BARGAINING POWER OF SUPPLIERS
- FIGURE 6. MODERATE THREAT OF NEW ENTRANTS
- FIGURE 7. LOW THREAT OF SUBSTITUTION
- FIGURE 8. HIGH COMPETITIVE RIVALRY
- FIGURE 9. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALGENOMICS MARKET
- FIGURE 10. GLOBAL GENOMICS MARKET SEGMENTATION, BY PRODUCT
- FIGURE 11. GENOMICS MARKET FOR CONSUMABLES AND REAGENT, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 12. GENOMICS MARKET FOR SERVICES, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 13. GENOMICS MARKET FOR INSTRUMENTS, SYSTEMS AND SOFTWARE, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 14. GLOBAL GENOMICS MARKET SEGMENTATION, BY TECHNOLOGY
- FIGURE 15. GENOMICS MARKET FOR SEQUENCING, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 16. GENOMICS MARKET FOR PCR, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 17. GENOMICS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 18. GENOMICS MARKET FOR MICROARRAY, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 19. GENOMICS MARKET FOR OTHERS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 20. GLOBAL GENOMICS MARKET SEGMENTATION, BY APPLICATION
- FIGURE 21. GENOMICS MARKET FOR FUNCTIONAL GENOMICS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 22. GENOMICS MARKET FOR EPIGENOMICS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 23. GENOMICS MARKET FOR PATHWAY ANALYSIS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 24. GENOMICS MARKET FOR BIOMARKER DISCOVERY, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 25. GENOMICS MARKET FOR OTHERS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 26. GLOBAL GENOMICS MARKET SEGMENTATION, BY END USER
- FIGURE 27. GENOMICS MARKET FOR CLINICAL RESEARCH, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 28. GENOMICS MARKET FOR ACADEMIC AND GOVERNMENT INSTITUTIONS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 29. GENOMICS MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 30. GENOMICS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 31. GENOMICS MARKET FOR OTHERS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 32. TOP WINNING STRATEGIES, BY YEAR, 2021-2023*
- FIGURE 33. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2021-2023*
- FIGURE 34. TOP WINNING STRATEGIES, BY COMPANY, 2021-2023*
- FIGURE 35. PRODUCT MAPPING OF TOP 10 PLAYERS
- FIGURE 36. COMPETITIVE DASHBOARD
- FIGURE 37. COMPETITIVE HEATMAP: GENOMICS MARKET
- FIGURE 38. TOP PLAYER POSITIONING, 2023
- FIGURE 39. COLOR GENOMICS, INC.: NET SALES, 2021-2023 ($BILLION)
- FIGURE 40. COLOR GENOMICS, INC.: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 41. COLOR GENOMICS, INC.: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 42. BGI GENOMICS: NET SALES, 2021-2023 ($BILLION)
- FIGURE 43. BGI GENOMICS: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 44. BGI GENOMICS: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 45. AGILENT TECHNOLOGIES: NET SALES, 2021-2023 ($BILLION)
- FIGURE 46. AGILENT TECHNOLOGIES: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 47. AGILENT TECHNOLOGIES: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 48. DANAHER CORPORATION: NET SALES, 2021-2023 ($BILLION)
- FIGURE 49. DANAHER CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 50. DANAHER CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 51. EPPENDORF AG: NET SALES, 2021-2023 ($BILLION)
- FIGURE 52. EPPENDORF AG: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 53. EPPENDORF AG: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 54. EUROFINS SCIENTIFIC SE: NET SALES, 2021-2023 ($BILLION)
- FIGURE 55. EUROFINS SCIENTIFIC SE: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 56. EUROFINS SCIENTIFIC SE: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 57. F. HOFFMANN-LA ROCHE LTD.: NET SALES, 2021-2023 ($BILLION)
- FIGURE 58. F. HOFFMANN-LA ROCHE LTD.: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 59. F. HOFFMANN-LA ROCHE LTD.: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 60. GE HEALTHCARE: NET SALES, 2021-2023 ($BILLION)
- FIGURE 61. GE HEALTHCARE: REVEN
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook